Nureca · NSE: NURECA · BSE: 543264

Q4 FY23 results · Jan–Mar 2023

Nureca reported revenue from operations of ₹21.23 crore (down 48.3% from Q4 FY22) and net loss of ₹1.53 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations21.2341.05−48.3%27.79−23.6%
Other income2.151.71+25.6%1.90+13.3%
Total income23.3742.76−45.3%29.68−21.3%
Profit before tax(1.97)(1.91)Loss widened0.27Turned loss
Net profit for the period(1.53)(1.40)Loss widened0.30Turned loss
EPS, basic (₹)(1.53)(1.40)Loss widened0.30Turned loss
Net margin (%)-7.2-3.41.1
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations21.2241.08−48.4%27.84−23.8%
Other income2.151.71+25.6%1.92+11.9%
Total income23.3742.79−45.4%29.76−21.5%
Profit before tax(2.30)(1.67)Loss widened0.01Turned loss
Net profit for the period(1.80)(1.17)Loss widened0.03Turned loss
EPS, basic (₹)(1.80)(1.17)Loss widened0.03Turned loss
Net margin (%)-8.5-2.80.1
Consolidated
Filed with BSE
24 May 2023, 17:44 IST
Board meeting
23 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
24 May 2023, 17:44 IST
Board meeting
23 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE